Trial intelligence / Profile preview

Aspylori trial of Helicobacter pylori eradication or pantoprazole versus no treatment for aspirin-associated gastric lesions

2007-003827-19Phase 4Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of pantoprazole, amoxicillin, clarithromycin and metronidazole in gastric ulcer and Helicobacter pylori infection (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Primary efficacy endpoint. Started Aug 2007; status: active.

02

Drugs

pantoprazoleamoxicillinclarithromycinmetronidazole
03

Conditions

gastric ulcerHelicobacter pylori infection

Beyond the preview

Go deeper on 2007-003827-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003827-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call